ASTRAZENECA PLC (AZNCF)
Clinical trial NCT05137262 updates: 1. completion date: 2026-08-31 → 2028-08-31 2. primary completion date: 2026-08-31 → 2028-08-31
Clinical trial NCT05137262 updates: 1. completion date: 2026-08-31 → 2028-08-31 2. primary completion date: 2026-08-31 → 2028-08-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical